Profile
Aljanae Reynolds is currently working as a Media Contact at Rapt Therapeutics, Inc. He previously worked as a Media Contact at Aduro BioTech, Inc.
Aljanae Reynolds active positions
| Companies | Position | Start |
|---|---|---|
| RAPT THERAPEUTICS, INC. | Public Communications Contact | - |
Former positions of Aljanae Reynolds
| Companies | Position | End |
|---|---|---|
| CHINOOK THERAPEUTICS, INC. | Public Communications Contact | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| RAPT THERAPEUTICS, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Aduro BioTech, Inc.
 Aduro BioTech, Inc. Pharmaceuticals: MajorHealth Technology Aduro BioTech, Inc. is a clinical-stage immunotherapy company, which engages in the discovery, development, and commercialization of therapies that transform the treatment of diseases, including cancer. Its technology platforms include STING Pathway Activator, B-select monoclonal antibody, and LADD, or Live, Attenuated, Double-Deleted Listeria monocytogenes. The company's platforms stimulate and/or regulate innate and adaptive immune responses, either as single agents or in combination with conventional therapies like chemotherapy and radiation as well as other novel immunotherapies. Aduro BioTech was founded in 2000 and is headquartered in Berkeley, CA. | Health Technology |
- Stock Market
- Insiders
- Aljanae Reynolds
